Date: 26 Apr 2008
Severe Recurrent Hypoglycemia after Gastric Bypass Surgery
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Bariatric surgery is, at present, the most effective method to achieve major, long-term weight loss in severely obese patients. Recently, severe recurrent symptomatic hyperinsulinemic hypoglycemia was described as a consequence of gastric bypass surgery (GBS) in a small series of patients with severe obesity. Pancreatic nesidioblastosis, a hyperplasia of islet cells, was postulated to be the cause, and subtotal or total pancreatectomy was the suggested treatment.
We observed that severe, disabling hypoglycemia after GBS occurred only in patients with loss of restriction. Whether restoration of gastric restriction might treat severe, recurrent hypoglycemia after GBS is unknown.
Therefore, gastric restriction was restored by surgical placement of a silastic ring (n = 8, first two patients with additional distal pancreatectomy) or an adjustable gastric band (n = 4) around the pouch in 12 consecutive patients presenting with severe hypoglycemia (blood glucose below 2.2 mM). At follow-up after restoration of gastric restriction (median follow-up 7 months, range 5 to 19 months), 11 patients demonstrated no hypoglycemic episodes, while one had recurrence of hypoglycemia and underwent distal pancreatectomy. Procedural mortality was 0% and morbidity 8.3%.
Patients suffering from severe recurrent hypoglycemia after GBS can be treated, in most cases, just by restoration of gastric restriction. Distal pancreatectomy should be considered a second-line treatment.
National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res. 1998;6 Suppl 2:51S–209S.
U.S. Department of Health and Human Services: Office of Disease Prevention and Health Promotion. Healthy people 2010. Nasnewsletter. 2000;15(3):3.
Pi-Sunyer FX. Comorbidities of overweight and obesity: current evidence and research issues. Med Sci Sports Exerc. 1999;31 Suppl 11:S602–8.PubMed
Safer DJ. Diet, behavior modification, and exercise: a review of obesity treatments from a long-term perspective. South Med J. 1991;84(12):1470–4.PubMed
CDC. State-specific prevalence of obesity among adults—United States, 2005. MMWR Morb Mortal Wkly Rep. 2006;55(36):985–8.
Zimmermann MB, Gubeli C, Puntener C, Molinari L. Overweight and obesity in 6–12 year old children in Switzerland. Swiss Med Wkly. 2004;134(35–36):523–8.PubMed
McTigue KM, Harris R, Hemphill B, Lux L, Sutton S, Bunton AJ, et al. Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;139(11):933–49.PubMed
Hafner RJ, Watts JM, Rogers J. Quality of life after gastric bypass for morbid obesity. Int J Obes. 1991;15(8):555–60.PubMed
Sigstad H. Effect of tolbutamide on the dumping syndrome. Scand J Gastroenterol. 1969;4(3):227–31.PubMed
Doppman JL, Chang R, Fraker DL, Norton JA, Alexander HR, Miller DL, et al. Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Ann Intern Med. 1995;123(4):269–73.PubMed
Holst JJ. Glucagonlike peptide 1: a newly discovered gastrointestinal hormone. Gastroenterology. 1994;107(6):1848–55.PubMed
- Severe Recurrent Hypoglycemia after Gastric Bypass Surgery
Volume 18, Issue 8 , pp 981-988
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Gastric bypass
- Gastric banding
- Gastric restriction
- Industry Sectors
- Author Affiliations
- 1. Berner Viszeralchirurgie and Schweizerisches Pankreaszentrum Klinik Beau-Site Bern, Bern, Switzerland
- 2. Adipositaszentrum Klinik Lindberg AG, Schickstrasse 11, 8400, Winterthur, Switzerland
- 3. Pathologie Länggasse, Bern, Switzerland
- 4. Institut für Pathologie Triemlispital Zürich, Zürich, Switzerland